Medical/Pharmaceuticals

Traditional Chinese Medicine Giant DEEJ Partners with 111 for Direct Sourcing

SHANGHAI, Sept. 12, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced the signing of a strategic cooperation agreement with Dong-E-E-Jiao Co., Ltd. ("DEEJ") (SZ: 000423), a leading company principally...

2019-09-12 23:16 7635

St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway

SYDNEY, Sept. 12, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that St Jude Children's Research Hospital has successfully completed the first stage of its ongoing phase I study of Kazia's in...

2019-09-12 21:10 7433

REDUCE FMR Study Shows Cardiac Dimensions' Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

Published in peer-reviewed Journal of the American College of Cardiology: Heart Failure KIRKLAND, Washington, Sept. 12, 2019 /PRNewswire/ -- Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with hea...

2019-09-12 19:04 2252

Gracell Announces Interim Readout of Investigation for First-in-class FasT CAR-19 in patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and Extension in Use of FasT CAR to Other Immune Cell Programs

SUZHOU and SHANGHAI, China, Sept. 11, 2019  /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced a positive continued clinical readout of a multi-center pilot study designed to evaluate the safety and efficacy of Gracell's f...

2019-09-12 05:00 2355

China Pharma Holdings, Inc. Has Entered into A Memorandum of Understanding With World Health Advanced Technologies, Ltd.

HAIKOU CITY, China, Sept. 11, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," "CPHI", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it has entered...

2019-09-11 20:00 7181

China SXT Pharmaceuticals, Inc. Granted to Establish Taizhou Research Center for Advanced TCMP Engineering Techniques

TAIZHOU, China, Sept. 11, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including A...

2019-09-11 19:00 7531

HCmed Innovations joins Wuxi International Life Science Innovation Park supported by AstraZeneca China

TAIPEI, Sept. 7, 2019 /PRNewswire/ -- Supported by the idea of garnering global wisdom to improve the healthcare system inChina, Wuxi Municipal Government, Wuxi High-tech District, and AstraZeneca, as a founding partner, officially inaugurated Wuxi International Life Science Innovation Park onSep...

2019-09-07 18:30 2114

WONTECH's Holmium laser 'Holinwon Prima' Received FDA approval

SEOUL, South Korea, Sept. 6, 2019 /PRNewswire/ -- WONTECH, a leading Korean medical device company, announced that its Holmium laser device, Holinwon Prima, received U.S. Food and Drug Administration approval. WONTECH’s Holmium Laser, ...

2019-09-06 18:36 1955

WuXi AppTec Launches DNA Encoded Library (DEL) Service Package "DELight" to Expedite Early Drug Discovery

SHANGHAI and BOSTON, Sept. 3, 2019 /PRNewswire/ -- WuXi AppTec today announced its launch of DELight, a novel DNA Encoded Library (DEL) service package, providing cost-effective and efficient hit finding services to expedite early drug discovery and bring new medicines to patients faster. DELigh...

2019-09-04 08:00 1805

The First Asia Pacific Psychiatry Symposium Takes Place

SHANGHAI, Sept. 3, 2019 The first-ever Asia Pacific Psychiatric Conference hosted by the Luye Pharma Group recently took place inNanjing. Dozens of psychiatrists and experts from 8 countries and regions includingChina, Korea, Malaysia, and Thailand gathered at the conference to hold discussions o...

2019-09-03 13:11 2218

CARsgen Therapeutics Receives US FDA Orphan Drug Designation For Fully Human Anti-BCMA (B Cell Maturation Antigen) Autologous Chimeric Antigen Receptor (CAR) T Cells For The Treatment Of Multiple Myeloma

SHANGHAI, Aug. 30, 2019 /PRNewswire/ -- CARsgen Therapeutics Inc., a clinical-stage biopharmaceutical company today announced the United States Food and Drug Administration (FDA) has granted orphan drug designation to its investigational CAR-T cell therapy fully human anti-BCMA (B Cell Maturation...

2019-08-31 10:54 5083

Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines

SHANGHAI, Aug. 29, 2019 /PRNewswire/ -- Luye Pharma Group (02186.HK) released its financial results for the first half of 2019 onAugust 28. The results show the company has achieved a revenue ofRMB 3.131 billion, up 42.1% year-on-year; EBITDA reachedRMB 1.263 billion, up 44.1% year-on-year, while...

2019-08-29 16:34 11782

Taiho Pharmaceutical Invests in New Venture Capital Fund

TOKYO, Aug. 29, 2019 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President and Representative Director:Masayuki Kobayashi) announced on August 29 that the company has entered into an agreement to invest up toUS$30 million in Remiges Biopharma Fund II, LP a biopharma venture capital...

2019-08-29 13:00 2466

Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020

1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million )                                   Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($16.4 Million) Non-GAAP Operating Income Up 15.0% YoY to RMB...

2019-08-28 04:16 8391

CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Texas

The procedure was performed by Joseph M. Berman, MD, an orthopedic surgeon at Arlington Orthopedics Associates (AOA),Arlington, TX KFAR SABA, Israel, Aug. 27, 2019 /PRNewswire/ — CartiHeal , developer of Agili-C™, a proprietary implant for the treatment of cartilage le...

2019-08-27 22:24 2023

Concord Medical Reports Financial Results for the First Half of 2019

BEIJING, Aug. 23, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced its unaudited consolidate...

2019-08-24 06:00 9559

Regulation Needs to Keep Pace With Global Cannabis Legalisation in 2019 - Prohibition Partners

LONDON, Aug. 22, 2019 /PRNewswire/ -- The number of countries to legalise medical cannabis has risen nine-fold in the last five years, as global attitudes towards cannabis have shifted in favour of liberalisation. In 2019, 43 countries have legalised medical cannabis, with a host more allowing p...

2019-08-22 19:54 2142

CStone submits an abstract on CS1001-201 trial to 2019 ASH Annual Meeting

SUZHOU, China, Aug. 20, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's CS1001-201 trial has been submitted to the upcoming 2019 American Society of Hematology (ASH) Annual Meeting. This will mark the first release of CS1001-201...

2019-08-20 10:18 5941

China SXT Pharmaceuticals, Inc. Announces Filing of Annual Report on Form 20-F for Year Ended March 31, 2019

TAIZHOU, China, Aug. 19, 2019 /PR Newswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), today annou...

2019-08-19 20:00 10679

WuXi AppTec Reports First Half 2019 Interim Results

* Revenue Accelerated 33.7% Year-Over-Year to RMB 5,894 Million * Gross Profit Up 30.0% Year-Over-Year to RMB 2,284 million[1] * Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year toRMB 1,179 Million * Small Molecule CDMO/CMO Pipeline has Grown to 800...

2019-08-19 19:20 5231
1 ... 185186187188189190191 ... 195